| BE0132-50MG
| InVivoMAb anti-mouse BTLA (CD272)
| 50 mg
| BioXCell
| in vivo BTLA stimulation, in vivo BTLA blockade
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0181-5MG
| InVivoMAb anti-mouse IL-9
| 5 mg
| BioXCell
| in vivo IL-9 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0099-25MG
| InVivoMAb recombinant CTLA-4-Ig (hum/hum)
| 25 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BE0173-100MG
| InVivoMAb anti-mouse IL-17A
| 100 mg
| BioXCell
| in vivo IL-17A neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0181-50MG
| InVivoMAb anti-mouse IL-9
| 50 mg
| BioXCell
| in vivo IL-9 neutralization
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0146-1MG
| InVivoMAb anti-mouse PD-1 (CD279)
| 1 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0144-50MG
| InVivoMAb anti-rat FcRn heavy chain heterodimers
| 50 mg
| BioXCell
| ELISA, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0179-50MG
| InVivoMAb anti-mouse CD1d (CD1.1)
| 50 mg
| BioXCell
| iNKT cell neutralization, in vivo CD1d blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0091-FAB-10MG
| InVivoMAb hamster IgG f(ab')2 fragments
| 10 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BE0152-1MG
| InVivoMAb anti-mouse MHC Class I (H-2Kk)
| 1 mg
| BioXCell
| in vivo administration
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0088-5MG
| InVivoMAb rat IgG1 isotype control, anti-horseradish peroxidase
| 5 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0108-5MG
| InVivoMAb anti-mouse MHC Class II (I-A/I-E)
| 5 mg
| BioXCell
| in vivo MHC II blockade, Functional assays, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0172-5MG
| InVivoMAb anti-mouse MHC Class I (H-2Kb)
| 5 mg
| BioXCell
| in vivo MHC II blockade, Functional assays, Purifi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0122-100MG
| InVivoMAb anti-rat Kappa Immunoglobulin Light Chain
| 100 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0175-50MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 50 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0124-1MG
| InVivoMAb anti-mouse CD276 (B7-H3)
| 1 mg
| BioXCell
| in vivo B7-H3 blockade, Flow cytometry
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0147-100MG
| InVivoMAb anti-mouse CD48
| 100 mg
| BioXCell
| in vivo CD48 blockade, in vitro CD48 blocking
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0175-25MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 25 mg
| BioXCell
| in vivo depletion of CD71+ cells
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0092-50MG
| InVivoMAb polyclonal human IgG
| 50 mg
| BioXCell
|
|
| Human
|
| Solicitar Precio
| Solicitar
|
| BE0161-100MG
| InVivoMAb anti-mouse DR5 (CD262)
| 100 mg
| BioXCell
| in vivo induction TRAIL-mediated apoptosis, in vit
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0120-100MG
| InVivoMAb anti-swine MHC Class I (SLAd)
| 100 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Pig
| Solicitar Precio
| Solicitar
|
| BE0167-1MG
| InVivoMAb anti-mouse/rat MHC Class II (I-Ek/RT1-D)
| 1 mg
| BioXCell
| in vivo blocking of antigen presentation, Flow cyt
|
| Mouse
| Mouse, Rat
| Solicitar Precio
| Solicitar
|
| BE0152-50MG
| InVivoMAb anti-mouse MHC Class I (H-2Kk)
| 50 mg
| BioXCell
| in vivo administration
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0101-1MG
| InVivoMAb anti-mouse PD-L1 (B7-H1)
| 1 mg
| BioXCell
| in vivo PD-L1 blockade, Immunofluorescence, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0136-50MG
| InVivoMAb anti-human E-Selectin
| 50 mg
| BioXCell
| Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0099-5MG
| InVivoMAb recombinant CTLA-4-Ig (hum/hum)
| 5 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BE0110-25MG
| InVivoMAb anti-mouse 4-1BBL (CD137L)
| 25 mg
| BioXCell
| in vivo 4-1BBL blockade, ELISA
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0132-100MG
| InVivoMAb anti-mouse BTLA (CD272)
| 100 mg
| BioXCell
| in vivo BTLA stimulation, in vivo BTLA blockade
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0153-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo stimulation of BTLA, in vitro stimulation
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0162-50MG
| InVivoMAb anti-human Glycophorin A (type M)
| 50 mg
| BioXCell
| in vitro GPA blockade
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0147-5MG
| InVivoMAb anti-mouse CD48
| 5 mg
| BioXCell
| in vivo CD48 blockade, in vitro CD48 blocking
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0186-100MG
| InVivoMAb anti-mouse PSGL-1 (CD162)
| 100 mg
| BioXCell
| in vivo PSGL-1 blockade, Immunohistochemistry (fro
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0183-5MG
| InVivoMAb anti-mouse Ter-119
| 5 mg
| BioXCell
| in vivo administration, in vitro erythrocyte negat
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0119-5MG
| InVivoMAb anti-mouse CD4
| 5 mg
| BioXCell
| in vivo CD4+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0122-25MG
| InVivoMAb anti-rat Kappa Immunoglobulin Light Chain
| 25 mg
| BioXCell
| in vivo B cell depletion in combination with anti-
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0146-25MG
| InVivoMAb anti-mouse PD-1 (CD279)
| 25 mg
| BioXCell
| in vivo blocking of PD-1/PD-L signaling
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0104-100MG
| InVivoMAb anti-mouse MHC Class I (H-2Kd)
| 100 mg
| BioXCell
| Purification of MHC peptide complexes, in vivo adm
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0099-50MG
| InVivoMAb recombinant CTLA-4-Ig (hum/hum)
| 50 mg
| BioXCell
|
|
|
|
| Solicitar Precio
| Solicitar
|
| BE0119-25MG
| InVivoMAb anti-mouse CD4
| 25 mg
| BioXCell
| in vivo CD4+ T cell depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0164-100MG
| InVivoMAb anti-mouse CTLA-4 (CD152)
| 100 mg
| BioXCell
| in vivo CTLA-4 neutralization, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0178-25MG
| InVivoMAb anti-mouse MHC class II (I-A)
| 25 mg
| BioXCell
| in vivo blockade of TCR stimulation, Flow cytometr
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0125-100MG
| InVivoMAb anti-mouse Jagged 2
| 100 mg
| BioXCell
| in vivo Jagged 2 neutralization
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0108-25MG
| InVivoMAb anti-mouse MHC Class II (I-A/I-E)
| 25 mg
| BioXCell
| in vivo MHC II blockade, Functional assays, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0168-5MG
| InVivoMAb anti-mouse V?2 TCR
| 5 mg
| BioXCell
| in vivo ?? T cell depletion, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0113-100MG
| InVivoMAb anti-mouse TIM-1 (CD365)
| 100 mg
| BioXCell
| in vivo TIM-1 blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0144-100MG
| InVivoMAb anti-rat FcRn heavy chain heterodimers
| 100 mg
| BioXCell
| ELISA, Flow cytometry
|
| Mouse
| Rat
| Solicitar Precio
| Solicitar
|
| BE0090-1MG
| InVivoMAb rat IgG2b isotype control, anti-keyhole limpet hemocyanin
| 1 mg
| BioXCell
|
|
| Rat
|
| Solicitar Precio
| Solicitar
|
| BE0118-1MG
| InVivoMAb anti-mouse CD8 (Lyt 2.1)
| 1 mg
| BioXCell
| in vivo CD8+ T cell depletion, Flow cytometry
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0171-1MG
| InVivoMAb anti-mouse TIM-4
| 1 mg
| BioXCell
| in vivo TIM-4 blockade, in vitro TIM-4 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0108-1MG
| InVivoMAb anti-mouse MHC Class II (I-A/I-E)
| 1 mg
| BioXCell
| in vivo MHC II blockade, Functional assays, Immuno
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|